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Background: Some women make an informed choice not to attend breast screening, whereas others may have forgotten about
the appointment. We report on a randomised trial that investigates whether a reminder letter affects attendance.
Methods: Women scheduled for a breast screening appointment were randomised to either receive a reminder letter a few days
before their breast screening appointment in addition to the standard invitation letter (intervention) or not (control). The primary
outcome was attendance within 30 days of the first offered appointment. Secondary outcomes were attendance within 90 and 180
days.
Results: In all, 11 383 (49.9%) women were randomised to the intervention and 11 445 (50.1%) to the control. In the intervention
arm, 7759 (68.2%) attended within 30 days of the first offered appointment compared with 7349 (64.2%) in the control arm. This
difference was significant (Po0.001). The odds ratio (OR) (95% confidence interval) for the primary end point was 1.19 (1.13–1.26).
This was not significantly affected by age, socioeconomic status or type of screen (prevalent or incident). Secondary endpoint
analyses supported these results. Results did differ, however, between the different centres studied.
Conclusions: This study found that postal reminders increase breast screening uptake, and could be practicable to implement in
the NHS Breast Screening Programme.
The effect of a screening programme on breast cancer mortality
depends, in part, upon high participation rates. The service
has a duty to allow the women invited to make up their own mind
as to whether to take up the offer of screening, but it is incumbent
on the provider to acknowledge that the service is offered
because screening has been found to prevent deaths from breast
cancer (Marmot et al, 2013). This independent review was
undertaken because of the recent and highly publicised
criticism of breast screening (Gøtzche and Nielsen, 2011), although
the concerns have been shown to be largely unwarranted
(Duffy et al, 2012). Although the Marmot review concluded
that the benefits of breast cancer screening far outweighed
the harms, there is no doubt that this could have had a
negative effect on breast screening attendance. Attending
regularly is important as cancers detected symptomatically in
women who have been invited to breast screening but have
not attended tend to be characterised by poor survival
(Lawrence et al, 2009).
There are a number of interventions that can improve
participation in cancer screening programmes. These include
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telephone, face-to-face, postal and text reminders (Fleming et al,
2012; Offman et al, 2014; Shankleman et al, 2014; Kerrison et al,
2015), GP endorsement (Hewitson et al, 2011), second timed
appointments for non-attenders (Stead et al, 1998) and flexibility
as regards appointment times (Offman et al, 2013).
In the UK’s National Health Service Breast Screening
Programme (NHSBSP), attendance rates for screening have
slowly declined nationally over the past few years. In 2004–2005,
74.6% of invited women aged 50–70 years attended, but this had
fallen to 72.2% by 2012–2013. The fall was more marked
for women in the first (prevalent) round of screening, where
attendance across the United Kingdom fell to 68.1%,
compared with 71.0% in 2005–2006, and is now below the
national minimum standard of 70% (NHS Cancer Screening
Programmes, 2007; NHS, 2013).
Some women who do not attend screening may have made an
informed decision not to attend, but others will have intended to go to
the appointment but simply forgot about it and therefore failed to
attend. Here we report on a study to estimate the effect on participation
of a postal reminder sent a few days before a woman’s appointment.
MATERIALS AND METHODS
We conducted a randomised controlled trial in three screening
units in the North-West of England: Bolton, Bury and Rochdale
(referred to as Bolton), Wigan and Liverpool. Women were
randomised 1 : 1 by each woman’s screening reference number (Sx
number) by a simple coin toss at the commencement of the study
to determine whether the intervention arm (to receive the
reminder letter) would be women with odd- or even-numbered
Sx numbers. The Sx number is a unique number allocated to
women when they first come to breast screening and which they
keep throughout their screening life. There was no reason to
believe that a difference existed between the characteristics of
women with odd and even Sx numbers as there is no systematic
practice with regard to the SX number allocated. Appointment and
attendance data were downloaded from the National Breast
Screening System database.
All women who were due to be invited to their regular three
yearly or first breast screening appointment within the time period
of this study received an invitation letter giving B3 weeks notice of
a dated and timed screening appointment, following normal
screening programme procedures. Approximately 2 weeks later, a
letter reminding them of this appointment was generated and sent
to the women in the intervention arm of the trial (Supplementary
Material). They received this letter a few days before their original
screening appointment. Women in the control arm did not receive
this reminder letter. Care was taken to ensure that the reminder
contained accurate information and was non-coercive in tone. The
important role of the reminder was to draw the invitee’s attention
to their imminent screening appointment. The letter is given in the
Supplementary Material.
Women were excluded from this study for the following
reasons:
(i) Women outside the age range 50–70 years. Although the
eligible age range has recently been extended to women aged
47–73 years, it has not yet been fully implemented in all
screening units.
(ii) Women under surveillance for a higher risk of breast
cancer due, for example, to a family history of breast
cancer.
(iii) Women who were recalled early because of either a suspicious
finding on a mammogram or a technical reason.
(iv) Women who had cancelled their appointment before
generation of the ‘reminder date’, and who did not rebook
at a later date (this exclusion was to ensure non-coercion of
those who had firmly decided not to attend).
Overall attendance in the two arms was compared using
descriptive tables of numbers and percentages attending, with
formal statistical inference using logistic regression. Data were
analysed using the STATA 12 software statistical package
(StataCorp, 2011), reporting deviance, w2 tests, odds ratios (OR)
and 95% confidence intervals. Subgroup analyses were performed
for prevalent and incident rounds, previous non-attenders, patient
age and socioeconomic status, which was measured by the index of
multiple deprivation (IMD) (Communities and Local Government,
2010). Four end points were used:
Attendance report 1 (primary end point):
 Attendance within 30 days of the date of first offered
appointment (FOA).
Attendance report 2 (secondary end points):
 Attendance within 90 days of the date of FOA;
 Attendance within 180 days of the date the episode was
opened, which is the time frame used to calculate screening
uptake;
 Attendance at the date and time of the FOA.
A power calculation, using the ‘sampsi’ option in STATA 12
(StataCorp, 2011) demonstrated that 20 000 women entered into
the study (10 000 in each arm) would confer 84% power to detect
an increase from 65 to 67% attendance as significant.
Ethical considerations. To ensure that the women receiving the
reminder letter did not feel pressurised into attending their
screening appointment if they had made a decision not to attend, it
was ensured, in consultation with experts and lay persons, that
these letters were non-coercive in tone. There were considered no
potential harms to the recipients of these letters. This study was
approved by the South Central Oxford A Research Ethics
Committee (application number 12/SC/0722). The trial was
registered with the ISRCTN registry, number 02240458 (http://
www.controlled-trials.com/ISRCTN02240458).
Randomised N = 27 385
Allocated to control
N = 11 445
Allocated to intervention 
N = 11 383
Analysed N = 11 383 Analysed N = 11 445
Excluded N = 4557*
* This figure included women outside the age range of 50–70 
years, women at a higher risk of breast cancer, early recalls and 
women who had cancelled their appointment prior to generation 
of the reminder date.
Figure 1. Study procedure (adapted from the CONSORT Transparent
Reporting of Trials).
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RESULTS
Overall, 27 385 women were recruited into this study. In all, 4557
women were excluded because of the reasons stated in the
Materials and Methods section. This left 22 828 women for the
analyses: 5619 (24.6%) from Wigan, 5726 (25.1%) from Liverpool
and 11 483 (50.3%) from Bolton. A total of 11 383 (49.9%) women
were randomised to receive the intervention of an invitation
reminder letter and 11 445 (50.1%) to the control arm (usual
invitation procedures) (Figure 1). Descriptive statistics of both
groups can be found in Table 1. As expected, there was no
significant difference between those randomised to receive the
invitation letter compared with those who were not, for socio-
economic status, age at FOA or whether it was a woman’s first
(prevalent) or subsequent (incident) screen.
In total, 15 108 (66.2%) of the women attended for screening
within 30 days of the FOA (Table 2). Those receiving the intervention
were significantly more likely to attend compared with those who did
not receive it (Po0.001): 7759 (68.2%) vs 7349 (64.2%). The OR of
attending screening within 30 days of the FOA if in the intervention
arm was 1.19 (1.13–1.26) compared with the control arm.
The following secondary end points were analysed:
(i) The OR of attending for women being screened within 90
days of the FOA was 1.16 (1.09–1.23), 8141 (71.1%) in the
control vs 8430 (74.1%) in the intervention arm attended
within 90 days FOA (Table 2).
(ii) The OR (95% CI) of women attending within 180 days of the
episode being opened was very similar at 1.14 (1.08–1.22),
8254 (72.1%) in the control vs 8511 (74.8%) in the
intervention arm attended within 180 days of the episode
being opened (Table 2).
(iii) In all, 10 749 (47.1%) of all women attended screening on
their FOA date, that is, they did not change their appointment
date. Of these, 5531 (49.9%) were in the intervention arm
compared with 5218 (45.6%) in the control arm, a significant
difference (Po0.001).
Similar effects of the intervention were observed for women
aged o60 years and women aged 60 years and above who attended
within 30 days of their FOA with ORs of attending of 1.19 (1.10–
1.29) and 1.19 (1.10–1.30), respectively: 3861 (62.5%) in the
control vs 4068 (66.5%) in the intervention arm for women o60
years of age and 3488 (66.2%) in the control vs 3691 (70.1%) in the
intervention arm for women 60 years of age and above (Table 3).
Analyses of 90 days after the FOA and 180 days after the episode
was opened for these women supported these results.
Overall, there were 6264 out of 22 828 (27.4%) women who were
offered a first (prevalent) screen and 16 564 (72.6%) who were
offered a subsequent (incident) screen. Screening attendance
within 30 days of FOA was significantly higher for women offered
an incident vs a prevalent screen irrespective of whether they were
randomised to the intervention or control arm (75.1% incident
screen compared with 42.7% prevalent screen for attending within
30 days of FOA). The low prevalent screen uptake is owing to the
Table 1. Patient characteristics by randomisation status
No intervention, N (%) Intervention, N (%) Test
11 445 (50.1) 11 383 (49.9)
Mean IMD score (range)a 27.4 (2.2–82.0) 27.4 (2.2–81.6) Wilcoxon’s rank-sum test
z¼0.01, P4z¼ 0.99
IMD, N (%)b
1st quintile 3392 (29.8) 3392 (30.0) w2 for trend
z¼0.33, P4z¼ 0.74
2nd quintile 2486 (21.9) 2384 (21.1)
3rd quintile 1878 (16.5) 1880 (16.6)
4th quintile 2336 (20.5) 2409 (21.3)
5th quintile 1279 (11.3) 1242 (11.0)
Mean age at first offered appointment (years) 59.0 (50–70) 59.0 (50–70) Wilcoxon’s rank-sum test
z¼0.36, P4z¼ 0.72
Age group (years), N (%)
o60 6179 (54.0) 6119 (53.8) Pearson’s w2 (1)¼ 0.12, P¼0.72
60þ 5266 (46.0) 5264 (46.2)
Screen type
Prevalent 3110 (27.2) 3154 (27.7) Pearson’s w2 (1)¼ 0.82, P¼0.37
Incident 8335 (72.8) 8229 (72.3)
Centre
Bolton 5745 (50.2) 5738 (50.4) Pearson’s w2 (2)¼ 0.30, P¼0.86
Wigan 2835 (24.8) 2784 (24.5)
Liverpool 2865 (25.0) 2861 (25.1)
Abbreviation: IMD¼ index of multiple deprivation.
aHigher score¼ lower socioeconomic status.
b1st quintile¼ lowest socioeconomic class.






intervention Intervention OR (95% CI) Significance
Attending within 30 days FOA
Yes 7349 (64.2) 7759 (68.2) 1.19 (1.13–1.26) Po0.001
No 4096 (35.8) 3624 (31.8)
Attending within 90 days FOA
Yes 8141 (71.1) 8430 (74.1) 1.16 (1.09–1.23) Po0.001
No 3304 (28.9) 2953 (25.9)
Attending within 180 days of episode opened
Yes 8254 (72.1) 8511 (74.8) 1.14 (1.08–1.22) Po0.001
No 3191 (27.9) 2872 (25.2)
Abbreviations: CI¼ confidence interval; FOA¼ first offered appointment; OR¼odds ratio.
aOf the first offered appointment date.
bOf when the episode was first opened, by randomization.
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fact that this includes women who have been invited before but
have never attended. To take this into account, Table 4 shows the
results for the prevalent round for younger women, that is, aged
50–52 years and the incident round for women 53–70 years by
whether they attended the previous screen or not. For younger
women in the prevalent round and for older women in the incident
round who had attended their routine screen 3 years previously,
attendance within 30 days of the FOA was significantly greater for
those in the intervention arm compared with those in the control
group. ORs (95% CI) were 1.21 (1.05–1.39) and 1.26 (1.17–1.37),
respectively. Analysis of 90 and 180 days supported these results
for both groups. For older women who had not attended their last
routine screen 3 years previously, numbers were too small for
significance, but attendance within 30 days was in the direction
showing benefit to women in the intervention arm compared with
the controls with an OR (95% CI) of 1.20 (0.65–2.21). For 90 and
180 days the ORs were close to 1.00, with ORs (95% CI) of 0.98
(0.54–1.79) and 0.98 (0.54–1.80), respectively.
There was significant heterogeneity of the effect of the
intervention between sites (P¼ 0.01), with only Bolton showing a
significant increase in attendance in the intervention group within
30 days of FOA, OR (95% CI) 1.30 (1.20–1.41). Wigan and
Liverpool had ORs (95% CI) of 1.10 (0.98–1.24) and 1.08
(0.97–1.21), respectively (Table 5), with both of borderline
significance (P¼ 0.08 and 0.1, respectively). Secondary results
showed a significant effect of the intervention for Bolton for both
90 and 180 days: OR (95% CI) 1.24 (1.15–1.36) and 1.22 (1.13–
1.33), respectively. Wigan showed a borderline effect for both 90
and 180 days: OR (95% CI) 1.13 (1.00–1.29) and 1.13 (0.998–1.29),
Table 3. Results by age at randomisation
Attenders/total (%)
End point No intervention Intervention OR (95% CI)
Age (years)
o60 Days from FOA
30 3861/6179 (62.5) 4068/6119 (66.5) 1.19 (1.10–1.29)
90 4298/6179 (69.6) 4442/6119 (72.6) 1.16 (1.07–1.25)
Days from episode opened
180 4365/6179 (70.6) 4495/6119 (73.5) 1.15 (1.06–1.25)
60þ years Days from FOA
30 3488/5266 (66.2) 3691/5264 (70.1) 1.19 (1.10–1.30)
90 3843/5266 (73.0) 3988/5264 (75.8) 1.15 (1.06–1.27)
Days from episode opened
180 3889/5266 (73.9) 4016/5264 (76.3) 1.14 (1.04–1.25)
Abbreviations: CI¼ confidence interval; FOA¼ first offered appointment; OR¼odds ratio.
Table 4. Results for women aged 50–52 yearsa and 53–70 yearsb
Attenders/total (%)
End point No intervention Intervention OR (95% CI)
screen
Prevalent round for women aged 50–52 years inclusive Days from FOA
30 1050/1772 (59.3) 1157/1814 (63.8) 1.21 (1.05–1.39)
90 1152/1772 (65.0) 1266/1814 (69.8) 1.24 (1.08–1.43)
Days from episode
opened
180 1164/1772 (65.7) 1280/1814 (70.6) 1.25 (1.08–1.44)
Incident round for women aged 53–70 years inclusive who
previously attended
Days from FOA
30 5313/7157 (74.30 5590/7120 (78.5) 1.26 (1.17–1.37)
90 5884/7157 (49.3) 6057/7120 (85.1) 1.23 (1.12–1.35)
Days from episode
opened
180 5964/7157 (83.3) 6106/7120 (85.8) 1.20 (1.09–1.32)
Incident round for women aged 53–70 years inclusive who did
not previously attended
Days from FOA
30 36/90 (40.0) 37/83 (44.6) 1.20 (0.65–2.21)
90 47/90 (52.2) 43/83 (47.8) 0.98 (0.54–1.79)
Days from episode
opened
180 48/90 (53.2) 44/83 (47.8) 0.98 (0.54–1.80)
Abbreviations: CI¼ confidence interval; FOA¼ first offered appointment; OR¼odds ratio.
aInclusive for prevalent screen.
bInclusive for incident screen by previously did and did not attend.
Table 5. ORs for attending screening within 30 days of first
offered appointment date by site
Attenders/total (%)
Sites No intervention Intervention OR (95% CI)
Bolton 3658/5745 (63.7) 3992/5738 (69.6) 1.30 (1.20–1.41)
Wigan 1962/2835 (69.2) 1986/2784 (71.3) 1.10 (0.98–1.24)
Liverpool 1729/2865 (60.4) 1781/2861 (62.3) 1.08 (0.97–1.21)
Abbreviations: CI¼ confidence interval; OR¼odds ratio.
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respectively, and Liverpool showed a nonsignificant effect with
ORs (95% CI) 1.03 (0.92–1.53) and 1.02 (0.91–1.15) for both 90
and 180 days, respectively.
Almost 30% of all the women in this study were in the lowest
socioeconomic quintile and only 11.1% in the highest. 21.5%,
16.6% and 20.9% were in the second, third and fourth lowest
socioeconomic quintile, respectively. Women in Liverpool were the
most deprived, with 42% in the lowest socioeconomic quintile and
only 2.6% in the highest. There were 31.9% of women in Bolton
who were in the lowest quintile and 9.1% in the highest. In
contrast, women in Wigan were more affluent, with 13.5% in the
lowest quintile and 23.9% in the highest. Logistic regression
analysis using the continuous variable of IMD score, where a
higher score indicates lower socioeconomic status, showed that a
woman was less likely to attend the lower her socioeconomic status
was, regardless of study arm. The effect of the intervention did not
vary by IMD score (results available from the authors).
DISCUSSION
This study shows a significant improvement from 72.5 to 75.1% in
eventual uptake for breast screening and an improvement from
64.2 to 68.2% in attending within 30 days of FOA as a result of a
postal reminder of a woman’s imminent breast screening
appointment. This indicates that the intervention, in addition to
improving overall uptake and therefore the public health impact of
the screening programme, also improves attendance at first booked
appointment, conferring a reduction in appointments wasted
through non-attendance and rebooking. Age, socioeconomic status
and type of screen (prevalent or incident) did not significantly
modify this effect.
The limitations of this study are the expedient of using odd or
even SX numbers for allocation to the trial arm rather than formal
randomisation, and the fact that the study took place entirely
within one region, the north-west of England. As noted above,
there is no systematic practice in allocation of odd or even SX
numbers, and thus we submit that this does not detract from the
validity of the results. The areas in which the study took place had
lower uptake than the national average, thus absolute uptake rates
cannot be generalised, although it is highly probable that the effect
of the intervention would apply nationally.
This study lends weight to conclusions from numerous other
studies that have looked at various additional interventions to
increase participation in breast cancer screening. A Cochrane
review concluded that active recruitment strategies including direct
reminders increased participation (Bonfill Cosp et al, 2001). This
was borne out by a more recent review incorporating other (non-
breast) cancer screening programmes (Camilloni et al, 2013).
A study in Italy of different methods of involving and informing
women about mammography found that a reminder letter
increased participation rate in 5360 Italian women aged 40–45
years by an average of 7.7% (Giordano et al, 2011). Studies in the
Republic of Ireland have found increases of 17.9–29.9% with
reminder letters (Hayes et al, 1999; Fleming et al, 2012). A survey
of 50–60-year-old women in Ontario, Canada explored the
acceptability of reminder letters for breast cancer screening. The
women found them to be useful and they also appeared to
influence the women’s decision to undergo mammography
screening (Kaczorowski et al, 2009).
Interestingly, for women aged 53–70 years who had not
previously attended, the intervention had no effect on ultimate
participation rates, but did improve attendance within 30 days of
FOA. This suggests that its effect in this group is only to change the
time of attendance to the FOA or near that time.
The more resource-intensive intervention of a telephone
reminder has also been observed to improve participation in
breast screening. In an area of East London, characterised by ethnic
diversity and populations of low socioeconomic status, a telephone
reminder campaign was observed to be associated with a greater
increase in participation, of the order of 10% (Offman et al, 2014).
However, the baseline participation rate was low in the area of that
study, around 50%, and thus there was considerably more room for
improvement. In addition, the telephone reminder came from the
invitee’s general practice, and so had an implicit GP endorsement.
A randomised trial in Belgium found that there was a 4% increase
in breast screening attendance among 3880 women aged 50–69
years who received a tailored telephone reminder compared with
controls (Goelen et al, 2010).
Another attractive option is the mobile phone text message,
often used to send reminders of dental appointments. This has the
immediacy of a telephone call, but does not have the confronta-
tional aspect or the human resource outlay. A randomised trial in
the London borough of Hillingdon tested whether text messages
were effective in improving attendance for women aged 47–53
years receiving their first invitation to breast screening and found
that it was, with an OR of 1.26 (1.05–1.48). The OR only including
those women who had a mobile phone number recorded (41%)
was 1.71 (1.29–2.26) (Kerrison et al, 2015).
It is interesting to note that the effect of a reminder letter was
greater in Bolton than in the other two sites. The effects in the
other two sites were, however, in the same direction, with at least
suggestive levels of significance. Additionally, Bolton recruited
much larger numbers than either of the other two sites, and so had
greater statistical power to find a significant result. However, it is
possible that local issues may modify the effect of the intervention
and these might require further investigation before implementa-
tion. It is difficult to see what might render Bolton more responsive
to the intervention than the other two areas. It is more deprived
than Wigan, but less so than Liverpool (all three areas are more
deprived than the England average). Although Bolton has the
largest ethnic diversity of the three areas, all have more than 80%
white British or Irish populations. In terms of health statistics,
Bolton does have more favourable results than the other two areas
in terms of a number of indices, including smoking-related deaths,
alcohol-related harm, obesity and physical activity (http://www.a-
pho.org.uk/default.aspx?QN=P_HEALTH_PROFILES). It may be
that populations that already have a greater degree of health
consciousness are more responsive to health reminders such as that
evaluated in this study.
A formal cost-effectiveness analysis is planned, which will
estimate the incremental cost-effectiveness ratios for the average
effect and for the range of effects observed in this trial.
It is desirable to find approaches that allow women to make an
informed choice about whether to attend for screening and to
make screening accessible and acceptable to maximise the
attendance of those who wish to be screened. It seems logical to
suggest that the intention to attend is a key concept and a strong
predictor of actual attendance. Therefore, those women with this
intention would benefit from practical interventions such as
reminders. The postal reminder evaluated here might be practic-
able to implement across the NHSBSP.
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